Telavancin Observational Use Registry (TOUR)

Completed

Conditions studied: Hospital Acquired Bacterial Pneumonia, Complicated Skin and Skin Structure Infections, Ventilator Associated Bacterial Pneumonia, Gram Positive Infection

In brief

The telavancin observational use registry (TOUR) will collect data to support study of the efficacy, safety, and pattern of use of telavancin in hospital-based inpatients and in outpatients being treated in infusion centers who are receiving clinician directed telavancin therapy.

Key facts

Study ID

NCT02288234

Run by

Cumberland Pharmaceuticals

People needed

1063

Starts

2014-11-01

Expected to finish

2017-10-01

Last updated by the study team

2019-01-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• received at least 1 dose of telavancin since January 1, 2015

You may not qualify if…

• Participation in an interventional research study or clinical trial involving telavancin after January 01, 2015

Where it is running

• Newland Medical Associates — Southfield, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.